MedTrace Logo

Effect of Using Virtual Glasses on Anxiety, Pain and Comfort During Uterine Tonus Assessment

NCT07545863 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 146

Last updated 2026-04-22

No results posted yet for this study

Summary

This randomized controlled experimental study aimed to determine the effect of using virtual glasses during uterine tone assessment on anxiety, pain and comfort. The hypotheses of this study were determined as follows:

H1-a: Using virtual reality glasses during uterine tone assessment affects anxiety.

H1-b: Using virtual reality glasses during uterine tone assessment affects pain.

H1-c: Using virtual reality glasses during uterine tone assessment affects comfort.

Conditions

  • Pregnancy Related

Interventions

OTHER

Virtual reality (VR) glasses are used as a midwifery intervention to reduce anxiety, stress, comfort and pain by drawing the individual's attention in a different direction. VR glasses are a stress in

Virtual reality (VR) glasses are used as a midwifery intervention to reduce anxiety, stress, comfort and pain by drawing the individual's attention in a different direction. VR glasses are a stress induction method that provides a fictional reality simulation with visual-visual orientation and three-dimensional views that allow the person to experience real-time perspective. Women may experience pain at different levels in the postpartum period. Pain affects the woman's emotional state and severe pain can cause anxiety in the woman. Pain in the postpartum period is usually caused by rapid and intermittent contractions of the uterus. The application of pressure to the uterine fundus by the midwife to evaluate the amount of postpartum bleeding and the tone of the uterus may increase the woman's pain and anxiety level and may also cause deterioration in her general comfort. Considering this information, it is thought that the relaxing effect of using virtual glasses during the uterine ton

Sponsors & Collaborators

  • Inonu University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2025-02-01
Completion
2025-02-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07545863 on ClinicalTrials.gov